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Affinity purification of a phage-displayed library, ex-
pressing random peptide 12-mers at the N terminus of
protein III, has identified 10 distinct novel sequences
which bind troponin C specifically. The troponin C-se-
lected peptides yield a consensus binding sequence of
(V/L)(D/E)XLKXXLXXLA. Sequence comparison re-
vealed as much as a 62.5% similarity between fT5, the
peptide sequence of the phage clone with the highest
level of binding to troponin C, and the N-terminal region
of troponin I isoforms. Biotinylated peptides corre-
sponding to library-derived sequences and similar se-
quences from various isoforms of troponin I were syn-
thesized shown to bind troponin C specifically. Alkaline
phosphatase fusion proteins of two of the phage clone
sequences bound troponin C specifically, and were spe-
cifically competed by both library-derived and native
troponin I peptides. Measurement of equilibrium disso-
ciation constants of the peptides by surface plasmon
resonance yielded dissociation constants for troponin C
as low as 0.43 mM for pT5; in contrast, dissociation con-
stants for calmodulin were greater than 6 mM for all
peptides studied. Nondenaturing polyacrylamide gel
electrophoresis demonstrated that pT5 formed a stable
complex with troponin C in the presence of calcium. We
also found that the pT5 peptide inhibited the maximal
calcium-activated tension of rabbit psoas muscle fibers.
Members of the EF-hand family of calcium-binding proteins
regulate the interaction of proteins in a wide variety of cellular
processes, from cell cycle progression to muscle contraction (1,
2). In particular, troponin C (TnC),1 the major regulatory pro-
tein in striated muscle contraction, is the calcium-binding com-
ponent of the ternary troponin complex. It regulates the acto-
myosin activity in a calcium-dependent manner, through its
association with tropomyosin and actin. Since TnC does not
interact directly with either of these proteins, it must transmit
the calcium signal to the thin filament by its interaction with
the other two components of the troponin complex, troponin I
(TnI) and troponin T (TnT). TnI, the inhibitory subunit, inhib-
its the actomyosin ATPase and binds actin, while TnT binds
tropomyosin. Because TnC is dependent on TnI and TnT for
transmission of the calcium signal to the actin filament, study-
ing the protein-protein interactions of TnC is critical to under-
standing the function of this molecule.
We investigated the characteristics of peptides that interact
with TnC using a phage-displayed combinatorial peptide li-
brary. Affinity selection of phage-displayed peptide libraries, a
technique based on screening a library of foreign peptides dis-
played on the surface of M13 bacteriophage (3–6), has become
a useful tool in recent years for characterizing protein-protein
interactions. Due to the physical linkage of the expressed pep-
tide and its genetic sequence, libraries with diversities of 108 to
1010 peptides (7) have been rapidly screened for a wide variety
of applications. To date, they have been used to map antibody
epitopes and mimotopes (5, 6, 8–10), and to discover peptide
ligands for membrane receptors (11) and cytosolic proteins
(12–14).
In this publication, we describe the affinity selection of a
phage-displayed library of random 12-mers with immobilized
rabbit fast skeletal TnC, and the isolation of novel sequences
which bind TnC. The sequences have a consensus motif of
(V/L)(D/E)XLKXXLXXLA, and are similar to a sequence within
the region of TnI, which is believed to play a role in the calcium-
dependent interaction with TnC (15–17). We have shown that
TnC-selected peptides from a phage-displayed library and sim-
ilar sequences from TnI bind TnC in a specific and biologically
relevant manner.
EXPERIMENTAL PROCEDURES
Random 12-mer Library Construction—The 12-mer random peptide
library was constructed as described (18) to yield 109 different recom-
binant M13 phage, which were plate-amplified to generate the library.
Preparation of TnC—TnC was purified either from rabbit muscle as
described (20) or following bacterial expression by Phenyl-Sepharose
chromatography as described by George et al. (21).
Isolation of TnC-binding Phage—Affinity selection of the 12-mer
library was used to isolate peptides that bound TnC as described (19).
Briefly, rabbit fast skeletal TnC was immobilized on polystyrene micro-
titer plates, and nonspecific binding was blocked by adding bovine
serum albumin (BSA). After three rounds of affinity purification, TnC
binding phage were eluted with 50 ml of 50 mM glycinezHCl (pH 2.0) and
neutralized with 50 ml of 200 mM sodium phosphate (pH 7.4). Recovered
phage were plated, and individual plaques isolated from bacterial
lawns. The DNA of isolates was prepared from overnight liquid cultures
with QIAprep Spin Miniprep Kits (Chatsworth, CA), and the culture
supernatants were stored at 4 °C for confirmation of TnC binding ac-
tivity (22). DNA was sequenced with an oligonucleotide primer up-
stream of the gene III cloning site of the M13 vector m663 (23).
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Synthetic Peptides—Peptides, corresponding to sequences from na-
tive TnI isoforms and sequences displayed by TnC-selected phage, were
synthesized by the Peptide Synthesis Facility at the University of North
Carolina, Chapel Hill, NC. The C termini of the peptides were ami-
dated, and a four-residue linker (GSGS) was added at their N termini
prior to biotinylation. The sequences included: pT3, biotin-GSGSS-
RVDELKLKLSTLVSR-NH2; pT5, biotin-GSGSSRLDYLKSSLLHLG-
SR-NH2; hcTnI, biotin-GSGSSRKLQLKTLLLQIAKQ-NH2; msTnI,
biotin-GSGSARRQHLKSVMLQIAAT-NH2; dTnIA, biotin-GSG-
SERKKKLRLLRKKAAE-NH2; dTnIV, biotin-GSGSERKKKLRL-
LLRKKVAE-NH2; APC, biotin-PKRHSGSYLVTSV-NH2; Amp1,
biotin-GSGSAPTPPKRSSSF-NH2.
Alkaline Phosphatase Fusion Recombinants and Proteins—Inserts of
phage clones T3 and T5 (fT3 and fT5) were amplified by polymerase
chain reaction with primers upstream and downstream of the M13 gene
III sequence, double-digested with XhoI and XbaI, and gel-purified. The
bacterial alkaline phosphatase (AP) fusion vector, pMY101 (24), was
digested with XbaI and SalI, gel-purified, ligated to M13 phage inserts,
and the ligation products used to transform electrocompetent DH5aF9
cells. DNA was prepared as above from cultures of individual colonies,
and recombinants identified by diagnostic digestion with SalI and con-
firmed by DNA sequencing. AP fusion proteins were prepared by grow-
ing recombinants in liquid culture with ampicillin selection to an optical
density (600 nm wavelength) of 0.3, addition of isopropyl-b-D-thiogalac-
topyranoside to a final concentration of 1 mM, followed by incubation at
37 °C for 18 h. The conditioned medium was recovered by centrifugation
at 4000 3 g for 10 min.
ELISA Binding Assays—Microtiter wells were coated with 50 ng of
rabbit fast skeletal TnC or 50 ng of bovine brain calmodulin (CaM;
Calbiochem-Novabiochem Corp., La Jolla, CA) in 100 mM NaHCO3 (pH
8.5) overnight at 4 °C. Nonspecific binding was blocked by incubation
with 1% BSA in 100 mM NaHCO3 (pH 8.5) for 1 h at room temperature.
The wells were washed with 0.1% Tween 20 in phosphate-buffered
saline (PBST). The peptides were added to the blocked wells in a 25-ml
volume (for a total reaction volume of 50 ml) and incubated at room
temperature for 2 h. For monovalent binding assays, 25 ml of 20 ng/ml
streptavidin-linked alkaline phosphatase (Sigma) was added to the
microtiter wells following the binding reaction and incubated for an
additional 30 min at room temperature, followed by multiple washes
with PBST. To detect bound peptides, 50 ml of alkaline phosphatase
buffer (1 M diethanolamine (pH 9.8), 1.0 mM MgCl2, 40 mM ZnSO4, 6.5
mM p-nitrophenyl phosphate) was added to each well and incubated 10
min at 37 °C to allow for full color development. The optical density of
the wells was then measured at 405 nm with a microplate spectropho-
tometer (Molecular Devices, Sunnyvale, CA).
Protein was adsorbed to microtiter plates as described above. For AP
fusion binding assays, 50 ml of conditioned medium was added to 50 ml
of 100 mM CaCl2 in PBST in blocked wells and incubated at room
temperature for 2 h. For competition assays, 100 ml of conditioned
medium and 100 ml of competitor were added to the blocked wells and
incubated at room temperature for 2 h. The wells were washed repeat-
edly with PBST. Bound AP fusion proteins were detected by the addi-
tion of 56 ml of alkaline phosphatase buffer, followed by measurement of
optical density at 405 nm with a microplate spectrophotometer.
Surface Plasmon Resonance Measurements—Equilibrium binding af-
finities of TnC for both library-derived and native TnI peptide se-
quences were determined by measurements of surface plasmon reso-
nance (25) on a BIAcore™ 2000 instrument (Biacore AB). The technique
of surface plasmon resonance for characterization of macromolecular
interactions has been discussed in several reviews (26–28). In brief,
ligands are attached to a carboxymethylated dextran gold surface and
analytes are injected over the peptide surface. Binding is measured as
an increase in resonance units (RU). Immunopure NeutrAvidin
(Pierce)-coated CM5 sensor chips (BIAcore™, Inc.) were prepared to
capture the biotinylated peptides onto the surface. NeutrAvidin was
dissolved at 1 mg/ml in HBS buffer (20 mM HEPES, 3.4 mM EDTA, 150
mM NaCl, 0.005% P-20, pH 7.4), and diluted 1:20 in 10 mM sodium
acetate, pH 6.0. NeutrAvidin was then covalently attached to the car-
boxyl groups on the surface of the CM5 sensor chip activated with 200
mM 1-ethyl-3-[3-demethylaminopropyl]carbodiimide hydrochloride and
50 mM N-hydroxysuccinimide. Following 10 injections of 100 mM HCl
(2-min contact time) over the NeutrAvidin-coated chip to achieve a
stable base line, biotinylated peptides were immobilized by one or two
injections of 100 nM peptide solution. After injection of 10 mM HCl to
remove unbound peptide, final surface densities of between 75 and 125
RU resulted.
To measure equilibrium binding affinities, increasing concentrations
of TnC or calmodulin were injected over the peptide surface. Running
buffer was HBS supplemented with 100 mM CaCl2 in place of EDTA.
Injection volumes were 60 ml at a flow rate of 10 ml/min. The steady
state binding levels, in RU, were recorded at the end of the injection.
The surface was regenerated with 50 mM EDTA, pH 8.0 (2-min contact
time). Binding to a control peptide, Amp1,2 was also measured. These
values were used to subtract nonspecific interactions. Background cor-
rected RU values were plotted as a function of added TnC or calmodulin
concentration, and nonlinear regression analysis (29) used to determine
equilibrium binding constants fit to a single-site binding model (25, 30,
31).
Nondenaturing Gel Electrophoresis—Analysis of the structural inter-
action of pT5 with TnC was performed as detailed by Farah et al. (17).
Purified TnC (6.7 mM) was incubated at room temperature for 30 min
with pT5 (6.7, 13.4, and 33.5 mM), human cardiac TnI (6.7 and 13.4 mM),
or Amp1 peptide (6.7, 13.4, and 33.5 mM). Samples were then diluted
with 1.5 volumes of 41.5 mM Tris, 133 mM glycine (pH 8.6), 2 mM
dithoithreitol, 0.02% bromphenol blue, 16.7% glycerol, and 10 mM
CaCl2. Samples were analyzed in 8% native gels containing 25 mM Tris,
80 mM glycine (pH 8.6), 0.5 mM CaCl2, and 10% glycerol.
Physiological Analysis—The activation and relaxing solutions and
the procedure for isolation of skinned fibers are described by Brandt et
al. (32). Briefly, the pCa 8 relaxing solution contains (as sodium salts):
9.8 mM EGTA, 0.2 mM CaEGTA, 5 mM MgATP, 5 mM ATP, 7.5 PO4, 40.1
mM propionate, 17.2 mM SO4, 10 mM MOPS at pH 7.00. The pCa 4.75
activating solution contains: 10 mM CaEGTA, 5 mM MgATP, 5 mM free
ATP, 10 mM MOPS, 7.5 mM PO4, propionate, and SO4 to adjust the final
solution to a standard ionic strength of 0.200 and monovalent cation
concentration of 155 mM. Single fibers were isolated from bundles of
rabbit psoas muscle skinned at 0 °C in skinning saline (5 mM
K2H2EGTA, 2 mM Na2MgATP, 5 mM Na2K2ATP, 130 mM potassium
propionate, 5 mM imidazole at pH 7.0). The maximal tension data were
collected on an apparatus as described previously (32).
RESULTS
Isolation and Characterization of TnC-binding Phage—In an
effort to study the peptide ligand preferences of TnC, we
screened a phage display combinatorial peptide library with
TnC. The library expressed random peptides 12 amino acids in
length at the N terminus of bacteriophage M13 protein III.
Immobilized rabbit fast skeletal TnC was used to affinity purify
TnC-binding phage from the library. After three rounds of
selection, isolated clones were tested for binding to TnC; ap-
proximately 90% of the isolates exhibited strong TnC binding
activity in an ELISA-based assay. DNA sequences from iso-
lated clones identified 10 unique TnC-binding peptides (Fig. 1).
Alignment of these sequences yields a consensus motif of (V/
L)(D/E)XLKXXLXXLA, where X represents positions that have
no apparent conservation. On the basis of these alignment
data, we concluded that residues at insert positions 4, 5, and 11
were the most critical for binding to troponin C, since they were
the most highly conserved. In in vitro phage binding assays,
2 Amp1, whose sequence is given under “Experimental Procedures,”
is an SH3 domain-binding sequence from c-Abl.
FIG. 1. Amino acid sequence of peptides displayed by TnC-
selected phage from the random 12-mer library. Residues within
the peptides that match the consensus have been aligned. Bold residues
are fixed in all library clones. Consensus residues ($50% frequency at
a given position) appear at the bottom of the figure; sequences included
in synthetic peptides are underlined.
Troponin C Antagonists from a Phage-displayed Library 23449
phage clones T3 and T5 (fT3 and fT5) exhibited the strongest
TnC binding activity. Alignments of these peptide sequences
(including the fixed serine and arginine residues from the M13
pIII protein) to known TnC ligands, namely TnI, TnT, and
actin, revealed 50–60% similarity to sequences in the N-ter-
minal regions of human cardiac and mouse skeletal TnI (Fig.
2).
Previous studies have shown that in addition to the well
characterized interaction of the C-terminal TnI-inhibitory pep-
tide with TnC, there are also important interactions between
the N-terminal region of TnI with TnC. Based on the similarity
between TnC-selected peptides and sequences in the N-termi-
nal region of TnI, we hypothesized that the corresponding
native sequences were sufficient for interaction with TnC. This
reasoning was supported by studies which have shown that
peptides from this region of TnI can bind TnC and can compete
the release of acto-S1-Tm ATPase inhibition by TnC (15, 16). It
is also notable that one of the best characterized non-lethal
indirect flight mutations in Drosophila melanogaster, heldup,2
is due to a single alanine to valine mutation at codon 55 in the
homologous N-terminal region of Drosophila TnI (33, 34).
In Vitro Peptide Binding Assays—To facilitate characteriza-
tion of the displayed sequences, biotinylated peptides were
synthesized corresponding to the sequences displayed by TnC-
selected phage clones (Fig. 1), and are hereafter denoted as pT3
and pT5. Due to their similarity to displayed peptides, se-
quences from the N-terminal region of native TnI isoforms
were also synthesized as biotinylated peptides. The native pep-
tides included human cardiac TnI-(44–59) (hcTnI), mouse fast
skeletal TnI-(13–28) (msTnI) and both normal (dTnIA) and
mutant (dTnIV) Drosophila flight muscle TnI-(42–57) (Fig. 2B).
To evaluate relative binding strength and specificity, the pep-
tides were assayed for direct binding to immobilized BSA,
rabbit fast skeletal TnC, and CaM (Fig. 3). Both of the library-
derived peptides bound TnC above background and exhibited
very little binding to CaM, a TnC-related protein. All four
TnI-derived sequences bound TnC, with hcTnI, dTnIA, and
dTnIV exhibiting the most robust binding signals. Binding to
CaM was pronounced for hcTnI, dTnIA, and dTnIV, but was
very low for msTnI. These data show that TnC-selected pep-
tides from a phage library can bind TnC specifically, and that
similar sequences from the N-terminal region of TnI isoforms
can also bind TnC.
AP Fusion Binding and Competition Assays—To confirm
binding of the library-derived sequences, and to determine
whether the biotinylated peptides could compete binding to
TnC, insert sequences from fT3 and fT5 were expressed as
bacterial alkaline phosphatase fusions using the vector
pMY101 (24). Assays of direct binding to TnC showed that both
fusion proteins bound TnC specifically (Fig. 4A), confirming
that the library-derived sequences were bona fide binders. The
fusion with highest binding activity, pT5AP, was used to assay
the ability of the biotinylated peptides to compete TnC binding
activity (Fig. 4B). The pT5AP fusion was most easily competed
by pT5, with an approximate IC50 of 300 nM, followed by hcTnI,
pT3, and msTnI. These results agreed with the relative binding
strengths determined by peptide ELISA (Fig. 3). The competi-
tion data provide evidence that the peptides are binding at, or
near, the same site on TnC.
BIAcore Measurement of Equilibrium Dissociation Con-
stants—Surface plasmon resonance was used to determine
equilibrium dissociation constants for native and library-de-
rived peptides. After biotinylated peptides were immobilized on
an avidin-coupled sensor chip, increasing concentrations of
TnC and CaM were injected over the immobilized peptides in
the presence of calcium, and steady state binding was meas-
ured in RU. Regeneration of the peptide-coated sensor chips
with EDTA resulted in a complete loss of TnC binding, which
indicates that the association requires the presence of calcium.
Background-corrected RU values were plotted as a function of
increasing TnC or CaM (Fig. 5), and equilibrium dissociation
constants for each peptide (Table I) were determined from the
response data; pT5 had the lowest Kd at 0.43 mM, followed by
hcTnI at 0.86 mM, and pT3 at 6.1 mM. The Kd of msTnI could not
be measured accurately, presumably because saturating con-
ditions could not be achieved. These dissociation constants
correspond roughly to the relative and approximate IC50s
measured by AP fusion competition assay (Fig. 4). Only the
hcTnI peptide exhibited a detectable response to increasing
CaM; however, its Kd was 6 mM. These data confirm that in the
presence of calcium the library-derived peptides bind TnC spe-
cifically and can exhibit dissociation constants higher than
those of the corresponding TnC sequences.
Assay of Interaction by Polyacrylamide Gel Electrophoresis—
Head and Perry (35) initiated the use of polyacrylamide gel
electrophoresis to demonstrate stable interactions between TnI
and TnC, and others have used similar techniques to analyze
the interaction of TnI peptides with TnC (15–17). The interac-
tion of pT5 with TnC was conducted using the modification of
Farah et al. (17). Purified TnC was mixed with pT5, and the
products of the binding reactions were resolved by nondenatur-
ing gel electrophoresis (Fig. 6). In the presence of calcium, pT5
associates with TnC in a stable manner, as indicated by the
presence of a lower mobility band and a reduced concentration
of free TnC. Full-length TnI also associates with TnC in a
FIG. 2. Native TnI isoforms are sim-
ilar to peptides displayed by TnC-se-
lected phage. Alignment of peptide se-
quence displayed by fT5 (pT5) with
native TnI isoforms. Human cardiac TnI-
(44–59) exhibits 37.5% identity and
56.25% similarity to pT5; mouse fast skel-
etal TnI-(13–28) exhibits 31.25% identity
and 62.5% similarity to pT5.
FIG. 3. Relative binding strength and specificity of synthetic
TnC-binding peptides. Binding to 50 ng of immobilized TnC or CaM,
or to BSA, was measured by ELISA. Values represent the average OD
at 405 nm for triplicate binding reactions done in the presence of 5 mM
peptide and 100 mM calcium.
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stable manner, as indicated by the presence of bands with
reduced mobility and a reduction in the concentration of free
TnC. The negative control peptide, Amp1, does not associate
with TnC, as indicated by the absence of bands with reduced
mobility and the presence of large amounts of free TnC. Similar
results were observed in experiments performed with radioac-
tively labeled TnC, generated by transcription-coupled trans-
lation in rabbit reticulocyte lysate (results not shown). These
results taken together demonstrate that the TnC-selected pT5
forms a stable complex with TnC in the presence of calcium.
Physiological Effects of Peptides—The physiological conse-
quences of naturally occurring TnC-binding peptides have been
studied by determining their effects on maximal calcium-in-
duced tension in skinned muscle fibers. The ability of pT5 to
disrupt activation of the troponin complex was assessed by
measuring its effect on maximal calcium-activated tension in
skinned rabbit psoas fibers. Addition of the pT5 peptide to the
pCa 4.75 activating solution inhibited maximal calcium ten-
sion. As shown in the tension trace in Fig. 7, the maximal
tension is reduced by 11, 38, and 66% at pT5 concentrations of
0.2, 0.5, and 1 mM, respectively. Studies on six fibers showed
that a 1 mM solution of pT5 reduces maximal tension by 59.5 6
3.4% (average 6 S.E.). Under the same conditions, the negative
control peptide APC has no effect on maximal calcium-acti-
vated tension. The effect of pT5 is fully reversible, as indicated
by the recovery of maximal activated calcium tension following
removal of the pT5 solution, washing of the fiber in pCa 8
relaxing solution, and reactivation. These results show that
pT5 binds TnC in a biologically relevant manner by demon-
strating that it is capable of disrupting the activation function
of the troponin complex.
DISCUSSION
In this study, we describe the affinity selection of phage-
displayed random peptide library with TnC, and the isolation
of 10 distinct sequences that bind TnC with a consensus of
(V/L)(D/E)XLKXXLXXLA. Comparison of these sequences with
other TnC-binding proteins revealed a striking similarity to a
sequence within the N-terminal region of TnI. We have dem-
onstrated that TnC-selected peptides from the phage-displayed
library and similar sequences from TnI bind TnC specifically,
with binding constants as low as 0.43 mM. In addition, we have
shown that a TnC-selected peptide forms a stable complex with
TnC in the presence of Ca21. When further ELISA studies were
performed to determine whether the binding of TnC-selected
peptides to rabbit fast skeletal TnC was calcium-dependent
(data not shown), we found that the binding of library-selected
FIG. 4. Alkaline phosphatase fusion binding and competition
assays. A, fusions of insert sequences from fT3 and fT5 to bacterial
alkaline phosphatase (pT3AP, pT5AP) bind TnC specifically by ELISA
assay. Fifty nanograms of TnC or CaM were immobilized in microtiter
wells. Values represent average OD at 405 nm for duplicate binding
reactions done in the presence of 50 mM CaCl2 and 50 ml of conditioned
medium. B, specific inhibition of AP fusion peptide interaction with
TnC by soluble peptide ligands. Fifty nanograms of TnC were immobi-
lized in microtiter wells. Increasing concentrations of competitor pep-
tide were incubated with pT5AP. Values represent average OD at 405
nm for duplicate binding reactions done in the presence of 100 ml of
competitor and 100 ml of conditioned medium containing pT5AP. The
negative control peptide (Neg.) is Amp1, an SH3 domain-binding
peptide.
FIG. 5. Measurement of TnC binding by surface plasmon res-
onance. Biotinylated peptides were immobilized on a NeutrAvidin-
coated sensor chip, and increasing concentrations of TnC were injected
over the immobilized peptides. Steady state binding was measured in
RU at the end of each injection. The graph shows background-corrected
RU values plotted as a function of increasing TnC concentration: l,
pT5; M, hcTnI; f, pT3; ‚, msTnI.
TABLE I
Equilibrium binding constants of troponin C-binding peptides
Equilibrium binding constants for troponin C-binding peptides in the
presence of calcium were determined by measurements of surface plas-
mon resonance. Steady state binding levels (in resonance units) were
plotted as a function of added TnC, and data was analyzed by nonlinear
regression analysis methods to determine equilibrium binding con-
stants by fitting to a single-site binding model.






a This value is approximate, as the binding constant is probably near
or above the limits of the BIAcore™ 2000 (see BIAcore 2000 Instrument
Handbook, p. A1, BIAcore AB).
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peptides and the mouse skeletal TnI peptide (msTnI) appeared
to be calcium-dependent, while the binding of peptides from
human cardiac TnI (hcTnI) and Drosophila TnI (dTnIA, dTnIV)
appeared to be calcium-independent.
We also demonstrated that a TnC-selected peptide binds
TnC in a biologically relevant manner, as demonstrated by its
inhibitory effect on calcium-induced tension generation in
skinned muscle fibers. Addition of a 1 mM solution of pT5
resulted in a reduction in maximal tension of approximately
60%. Although the concentration of pT5 necessary to cause the
reduction is much higher than its dissociation constant for
TnC, it is important to realize that there are many stabilizing
interactions among the subunits of the troponin complex. This
peptide is homologous to only a portion of the regulatory pep-
tide (Rp) of TnI, and x-ray crystallographic studies on the
TnC-regulatory protein complex indicate will that pT5 will only
disrupt interactions between TnI and the structural C-terminal
domain of TnC (36). This most likely explains why a small
peptide, like pT5, requires a high concentration to impair the
troponin activation in situ. Taken together, these results dem-
onstrate the power of using phage-displayed combinatorial li-
braries to map native protein-protein interactions (3, 7). The
results also implicate that this short N-terminal sequence
within TnI plays an important role in the interaction of TnC
and TnI in vivo, which is supported by the results of previous
studies on the interaction of TnC and TnI.
The majority of previously published studies on the interac-
tion of TnC and TnI have concentrated on the TnI inhibitory
peptide (Ip), which consists of the C-terminal residues 104–115
of TnI. Several different groups have demonstrated that pro-
teolytic fragments and synthetic peptides of the inhibitory re-
gion of TnI mimic the activity of TnI in their ability to inhibit
the actomyosin ATPase activity and bind TnC resulting in the
release of inhibition (16, 37–43). In recent years, however, a
number of studies have also been done on the function of the
N-terminal region of TnI. Farah et al. (17) and Ngai and
Hodges (15) have demonstrated that addition of peptides from
the N-terminal region of TnI (TnI-(1–40), TnI-(10–40), and
TnI-(20–40)) can prevent TnC from fully releasing the inhibi-
tion of actomyosin ATPase induced by TnI or Ip, although the
N-terminal peptides do not directly inhibit actomyosin ATPase
activity. In addition, both groups have demonstrated that pep-
tides from the N-terminal region of TnI, namely the Rp (resi-
dues 1–40) and TnI-(1–98), can form stable complexes with
TnC in the presence of calcium.3 The results of these studies
have led to the hypothesis that the N-terminal region of TnI is
responsible for the structural interaction with TnC.
Furthermore, Katayama and Nozaki (16) have demonstrated
that a short synthetic peptide, consisting of residues 10–25 of
the N-terminal region of rabbit fast skeletal TnI, could form a
stable complex with TnC in the presence of Ca21. Taken along
with our findings that a synthetic peptide consisting of residues
13–28 of mouse fast skeletal TnI binds TnC, and that a similar
TnC-selected peptide can form a stable complex with TnC in
the presence of Ca21, it is reasonable to suspect that the min-
imal sequence necessary for the interaction of the N-terminal
region of TnI and TnC is bounded by these two native peptide
sequences. In addition, we believe that we may have identified
residues within the N-terminal region of TnI critical for bind-
ing to TnC, as they were highly conserved in the library-
derived peptides. These results can be extended in the future
by mutagenesis of these conserved residues within TnI, as well
as performing a systematic scan of peptides spanning this
region of TnI, and testing their binding to TnC. The peptides
produced in this study will also serve as useful reagents to
study the interaction of the N terminus of TnI with truncated
forms of TnC to determine where the peptides are binding to
TnC.
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